CD34 and acute lymphoblastic leukemia: We also documented the cytotoxic effects of NVP-BAG956 and MK-2006 against a T-ALL cell subpopulation (CD34+/CD7,−/CD4−) enriched for cancer stem cells (or leukemia initiating cells, LICs).